BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 29507376)

  • 1. Clinical phenotype and molecular analysis of a homozygous ABCB11 mutation responsible for progressive infantile cholestasis.
    Imagawa K; Hayashi H; Sabu Y; Tanikawa K; Fujishiro J; Kajikawa D; Wada H; Kudo T; Kage M; Kusuhara H; Sumazaki R
    J Hum Genet; 2018 May; 63(5):569-577. PubMed ID: 29507376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a bile salt export pump deficiency model using patient-specific induced pluripotent stem cell-derived hepatocyte-like cells.
    Imagawa K; Takayama K; Isoyama S; Tanikawa K; Shinkai M; Harada K; Tachibana M; Sakurai F; Noguchi E; Hirata K; Kage M; Kawabata K; Sumazaki R; Mizuguchi H
    Sci Rep; 2017 Feb; 7():41806. PubMed ID: 28150711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis.
    Noe J; Kullak-Ublick GA; Jochum W; Stieger B; Kerb R; Haberl M; Müllhaupt B; Meier PJ; Pauli-Magnus C
    J Hepatol; 2005 Sep; 43(3):536-43. PubMed ID: 16039748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
    Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R
    Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic differences in PFIC2 and BRIC2 correlate with protein stability of mutant Bsep and impaired taurocholate secretion in MDCK II cells.
    Kagawa T; Watanabe N; Mochizuki K; Numari A; Ikeno Y; Itoh J; Tanaka H; Arias IM; Mine T
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G58-67. PubMed ID: 17947449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutation.
    Ellinger P; Stindt J; Dröge C; Sattler K; Stross C; Kluge S; Herebian D; Smits SHJ; Burdelski M; Schulz-Jürgensen S; Ballauff A; Schulte Am Esch J; Mayatepek E; Häussinger D; Kubitz R; Schmitt L
    World J Gastroenterol; 2017 Aug; 23(29):5295-5303. PubMed ID: 28839429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
    Davit-Spraul A; Fabre M; Branchereau S; Baussan C; Gonzales E; Stieger B; Bernard O; Jacquemin E
    Hepatology; 2010 May; 51(5):1645-55. PubMed ID: 20232290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-chain ubiquitination is associated with the degradation rate of a cell-surface-resident bile salt export pump (BSEP/ABCB11).
    Hayashi H; Sugiyama Y
    Mol Pharmacol; 2009 Jan; 75(1):143-50. PubMed ID: 18829893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional rescue of an ABCB11 mutant by ivacaftor: A new targeted pharmacotherapy approach in bile salt export pump deficiency.
    Mareux E; Lapalus M; Amzal R; Almes M; Aït-Slimane T; Delaunay JL; Adnot P; Collado-Hilly M; Davit-Spraul A; Falguières T; Callebaut I; Gonzales E; Jacquemin E
    Liver Int; 2020 Aug; 40(8):1917-1925. PubMed ID: 32433800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2.
    Gonzales E; Grosse B; Cassio D; Davit-Spraul A; Fabre M; Jacquemin E
    J Hepatol; 2012 Sep; 57(3):695-8. PubMed ID: 22609309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2.
    Maggiore G; Gonzales E; Sciveres M; Redon MJ; Grosse B; Stieger B; Davit-Spraul A; Fabre M; Jacquemin E
    J Hepatol; 2010 Nov; 53(5):981-6. PubMed ID: 20800306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps.
    Hayashi H; Sugiyama Y
    Hepatology; 2007 Jun; 45(6):1506-16. PubMed ID: 17538928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families.
    Strautnieks SS; Byrne JA; Pawlikowska L; Cebecauerová D; Rayner A; Dutton L; Meier Y; Antoniou A; Stieger B; Arnell H; Ozçay F; Al-Hussaini HF; Bassas AF; Verkade HJ; Fischler B; Németh A; Kotalová R; Shneider BL; Cielecka-Kuszyk J; McClean P; Whitington PF; Sokal E; Jirsa M; Wali SH; Jankowska I; Pawłowska J; Mieli-Vergani G; Knisely AS; Bull LN; Thompson RJ
    Gastroenterology; 2008 Apr; 134(4):1203-14. PubMed ID: 18395098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep/Abcb11) correlate with severity of cholestatic diseases.
    Lam P; Pearson CL; Soroka CJ; Xu S; Mennone A; Boyer JL
    Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1709-16. PubMed ID: 17855769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of Progressive Familial Intrahepatic Cholestasis Type 2 Phenotype After Living-donor Liver Transplantation: A Case Report.
    Masahata K; Uehara S; Ibuka S; Nakahata K; Hasegawa Y; Kondou H; Kubitz R; Ueno T
    Transplant Proc; 2016 Nov; 48(9):3156-3162. PubMed ID: 27932171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate.
    Gonzales E; Grosse B; Schuller B; Davit-Spraul A; Conti F; Guettier C; Cassio D; Jacquemin E
    Hepatology; 2015 Aug; 62(2):558-66. PubMed ID: 25716872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive familial intrahepatic cholestasis.
    Jacquemin E
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype-Genotype Correlation of North Indian Progressive Familial Intrahepatic Cholestasis type2 Children Shows p.Val444Ala and p.Asn591Ser Variants and Retained BSEP Expression.
    Mitra S; Das A; Thapa B; Kumar Vasishta R
    Fetal Pediatr Pathol; 2020 Apr; 39(2):107-123. PubMed ID: 31335238
    [No Abstract]   [Full Text] [Related]  

  • 19. Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11.
    Hayashi H; Takada T; Suzuki H; Akita H; Sugiyama Y
    Hepatology; 2005 Apr; 41(4):916-24. PubMed ID: 15791618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations.
    Soroka CJ; Boyer JL
    Mol Aspects Med; 2014 Jun; 37():3-14. PubMed ID: 23685087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.